Follow
Teni Boulikas
Teni Boulikas
CEO, Regulon, Inc.
Verified email at regulon.com - Homepage
Title
Cited by
Cited by
Year
Silver staining of proteins in polyacrylamide gels
W Wray, T Boulikas, VP Wray, R Hancock
Analytical biochemistry 118 (1), 197-203, 1981
39471981
Cisplatin and platinum drugs at the molecular level
T Boulikas, M Vougiouka
Oncology reports 10 (6), 1663-1682, 2003
10952003
Nuclear localization signals (NLS).
T Boulikas
Critical reviews in eukaryotic gene expression 3 (3), 193-227, 1993
4361993
Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs
T Boulikas, M Vougiouka
Oncology reports 11 (3), 559-595, 2004
3702004
Clinical overview on Lipoplatin: a successful liposomal formulation of cisplatin
T Boulikas
Expert opinion on investigational drugs 18 (8), 1197-1218, 2009
3492009
Chromatin domains and prediction of MAR sequences
T Boulikas
International review of cytology 162, 279-388, 1996
3471996
Putative nuclear localization signals (NLS) in protein transcription factors
T Boulikas
Journal of cellular biochemistry 55 (1), 32-58, 1994
2961994
Designing platinum compounds in cancer: structures and mechanisms
T Boulikas, A Pantos, E Bellis, P Christofis
Cancer Ther 5, 537-583, 2007
2852007
Nature of DNA sequences at the attachment regions of genes to the nuclear matrix
T Boulikas
Journal of cellular biochemistry 52 (1), 14-22, 1993
2591993
Lipoplatin formulation review article
GP Stathopoulos, T Boulikas
Journal of drug delivery 2012, 2012
2482012
Points of contact between histone H1 and the histone octamer.
T Boulikas, JM Wiseman, WT Garrard
Proceedings of the National Academy of Sciences 77 (1), 127-131, 1980
2091980
Immunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompetent Semliki forest virus vector carrying the human interleukin-12 …
H Ren, T Boulikas, A Söling, PC Warnke, NG Rainov
Journal of neuro-oncology 64, 147-154, 2003
1952003
Pharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin): phase I study
GP Stathopoulos, T Boulikas, M Vougiouka, G Deliconstantinos, ...
Oncology reports 13 (4), 589-595, 2005
1942005
Low toxicity and anticancer activity of a novel liposomal cisplatin (Lipoplatin) in mouse xenografts
T Boulikas
Oncology reports 12 (1), 3-12, 2004
1882004
Systemic Lipoplatin infusion results in preferential tumor uptake in human studies
T Boulikas, GP Stathopoulos, N Volakakis, M Vougiouka
Anticancer Research 25 (4), 3031-3039, 2005
1822005
Functional organization in the nucleus
R Hacock, T Boulikas
International review of cytology 79, 165-214, 1982
1771982
Relation between carcinogenesis, chromatin structure and poly (ADP-ribosylation)
T Boulikas
Anticancer research 11 (2), 489-527, 1991
1711991
Phosphorylation of transcription factors and control of the cell cycle.
T Boulikas
Critical reviews in eukaryotic gene expression 5 (1), 1-77, 1995
1631995
Viral and non-viral vectors in gene therapy: technology development and clinical trials
K Lundstrom, T Boulikas
Technology in cancer research & treatment 2 (5), 471-485, 2003
1612003
Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
T Boulikas
US Patent 6,511,676, 2003
1382003
The system can't perform the operation now. Try again later.
Articles 1–20